Vehicle Indication Modality Delivery route Vehicle Preclinical Clinical (Phase 1 and 2) Lipid Nanoparticle Indication Viral infection Modality mRNA Delivery route IM Discovery Preclinical Clinical (Phase 1 and 2) Indication Liver disease Modality Cas9 mRNA + SgRNA Delivery route IV Discovery Preclinical Clinical (Phase 1 and 2) With the improved delivery specificity and efficiency, our AccuLNP® platform can carry a variety of genetic cargos to the disease site and has the potential to be applied across a wide range of genetic disorders including central nervous system (CNS), liver, and cancer.
